These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9701357)

  • 1. Research on drug resistance unearths many molecules, many mechanisms.
    Reynolds T
    J Natl Cancer Inst; 1998 Aug; 90(15):1120-2. PubMed ID: 9701357
    [No Abstract]   [Full Text] [Related]  

  • 2. Transporter molecules in multidrug resistance.
    Scheper RJ; Scheffer GL; Flens MJ; van der Valk P; Broxterman HJ; Izquierdo MA
    Cytotechnology; 1996; 19(3):187-90. PubMed ID: 8862005
    [No Abstract]   [Full Text] [Related]  

  • 3. Biology of the multidrug resistance-associated protein, MRP.
    Loe DW; Deeley RG; Cole SP
    Eur J Cancer; 1996 Jun; 32A(6):945-57. PubMed ID: 8763335
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance.
    Twentyman PR; Versantvoort CH
    Eur J Cancer; 1996 Jun; 32A(6):1002-9. PubMed ID: 8763341
    [No Abstract]   [Full Text] [Related]  

  • 5. P-glycoprotein: its role in drug resistance.
    Ling V
    Am J Med; 1995 Dec; 99(6A):31S-34S. PubMed ID: 8585532
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological considerations in the modulation of multidrug resistance.
    Fisher GA; Lum BL; Hausdorff J; Sikic BI
    Eur J Cancer; 1996 Jun; 32A(6):1082-8. PubMed ID: 8763350
    [No Abstract]   [Full Text] [Related]  

  • 7. P-glycoprotein--a mediator of multidrug resistance in tumour cells.
    Germann UA
    Eur J Cancer; 1996 Jun; 32A(6):927-44. PubMed ID: 8763334
    [No Abstract]   [Full Text] [Related]  

  • 8. 1st International Conference on Reversal of Multidrug Resistance in Cancer. St. Gallen, Switzerland, 1-3 September 1994.
    Hamblin TJ
    Leuk Res; 1995 Jun; 19(6):427-8. PubMed ID: 7596156
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis and reversal of multidrug resistance in paediatric cancers.
    Chan HS; Grogan TM; DeBoer G; Haddad G; Gallie BL; Ling V
    Eur J Cancer; 1996 Jun; 32A(6):1051-61. PubMed ID: 8763347
    [No Abstract]   [Full Text] [Related]  

  • 10. Unanswered questions about multidrug resistance.
    Beck WT
    Cytotechnology; 1996; 19(3):177-9. PubMed ID: 8862003
    [No Abstract]   [Full Text] [Related]  

  • 11. Multidrug resistance reversal in childhood malignancies--potential for a real step forward?
    Pinkerton CR
    Eur J Cancer; 1996 Apr; 32A(4):641-4. PubMed ID: 8695268
    [No Abstract]   [Full Text] [Related]  

  • 12. P-glycoprotein mediated multidrug resistance and its implications for pathology.
    Trambas CM; Muller HK; Woods GM
    Pathology; 1997 May; 29(2):122-30. PubMed ID: 9213329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of protein kinase C in multidrug resistance.
    O'Brian CA; Ward NE; Gravitt KR; Fan D
    Cancer Treat Res; 1994; 73():41-55. PubMed ID: 7710909
    [No Abstract]   [Full Text] [Related]  

  • 14. The genetic basis of resistance to cancer chemotherapy.
    Woodhouse JR; Ferry DR
    Ann Med; 1995 Apr; 27(2):157-67. PubMed ID: 7632408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyclosporin A reverses steroid-resistance induced by P-glycoprotein in patients with SLE].
    Tanaka Y; Awazu Y; Saito K; Fujii K; Ota T; Kohno K; Eto S
    Nihon Rinsho Meneki Gakkai Kaishi; 1999 Dec; 22(6):406-9. PubMed ID: 10726475
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of multidrug resistance in acute myeloid leukaemia and other haematological malignancies.
    Sonneveld P
    Eur J Cancer; 1996 Jun; 32A(6):1062-9. PubMed ID: 8763348
    [No Abstract]   [Full Text] [Related]  

  • 17. P-glycoprotein and swelling-activated chloride channels.
    Bond TD; Higgins CF; Valverde MA
    Methods Enzymol; 1998; 292():359-70. PubMed ID: 9711567
    [No Abstract]   [Full Text] [Related]  

  • 18. MDR1/P-glycoprotein in haematological neoplasms.
    Marie JP; Zhou DC; Gurbuxani S; Legrand O; Zittoun R
    Eur J Cancer; 1996 Jun; 32A(6):1034-8. PubMed ID: 8763345
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical multidrug resistance in cancer: a multifactorial problem.
    Lehnert M
    Eur J Cancer; 1996 Jun; 32A(6):912-20. PubMed ID: 8763332
    [No Abstract]   [Full Text] [Related]  

  • 20. Multidrug resistance: overcoming the good, the bad, and the ugly.
    Rund D
    Leuk Lymphoma; 2010 Oct; 51(10):1771-2. PubMed ID: 20846098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.